{'_data': [['Unknown',
            [['GI',
              u'Abdominal pain 3.7 3.0 6.6 4.8 Dyspepsia 2.7 2.2 3.6 3.5 Acid regurgitation 1.9 2.4 2.0 4.3 Nausea 1.9 2.4 3.6 4.0 Abdominal distension 1.0 1.4 1.0 0.8 Constipation 0.8 1.6 3.1 1.8 Diarrhoea 0.6 0.5 3.1 1.8 Dysphagia 0.4 0.5 1.0 0.0 Flatulence 0.4 1.6 2.6 0.5 Gastritis 0.2 1.1 0.5 1.3 Gastric ulcer 0.0 1.1 0.0 0.0 Oesophageal ulcer 0.0 0.0 1.5 0.0 Musculoskeletal Musculoskeletal pain 2.9 3.2 4.1 2.5 (bone, muscle or joints) Muscle cramps 0.2 1.1 0.0 1.0 Neurological Headache 0.4 0.3 2.6 1.5 The following undesirable effects have also been reported in clinical trials and/or post marketing: Very common: > 1/10; Common: > 1/100 to < 1/10; Uncommon: > 1/1,000 to < 1/100; Rare: > 1/10,000 to < 1/1,000; Very rare: < 1/10,000; Not known: cannot be estimated from the available data. Immune system disorders Rare: Hypersensitivity reactions including urticaria and angioedema. Metabolism and nutrition disorders Rare: Symptomatic hypocalcaemia, generally in connection with predisposing conditions (see section 4.4). Nervous system disorders Common: Headache. Not known: Dizziness, dysgeusia. Eye disorders Rare: Uveitis, scleritis, episcleritis. Ear and labyrinth disorders Not known: Vertigo. Gastrointestinal disorders Common: Abdominal pain, dyspepsia, constipation, diarrhoea, flatulence, oesophageal ulcers*, dysphagia*, abdominal distension, acid regurgitation. Uncommon: Nausea, vomiting, gastritis, oesophagitis* oesophageal erosions*, melaena. Rare: Oesophageal stricture*, oropharyngeal ulceration*, upper gastrointestinal PUB (perforations, ulcers, bleeding) (see section 4.4) *See section 4.2 and 4.4. Skin and subcutaneous tissue disorders Uncommon: Rash, pruritus, erythema, alopecia. Rare: Rash with photosensitivity. Very rare: Isolated cases of severe skin reactions including Stevens-Johnson syndrome and toxic epidermal necrolysis have been reported. Musculoskeletal and connective tissue disorders Common: Musculoskeletal pain (bones, muscles or joints). Rare: Severe musculoskeletal pain (bones, muscles or joints) (see section 4.4). Osteonecrosis of the jaw has been reported in patients treated by bisphosphonates. The majority of the reports refer to cancer patients, but such cases have also been reported in patients treated for osteoporosis. Osteonecrosis of the jaw is generally associated with tooth extraction and/or local infection (including osteomyelitis). Diagnosis of cancer, chemotherapy, radiotherapy, corticosteroids, poor oral hygiene and smoking are also deemed as risk factors (see section 4.4). Not known: Stress fractures of the proximal femoral shaft (see section 4.4), joint swelling.']]]],
 '_pages': [6, 8],
 u'_rank': 1,
 u'_type': u'LSFU'}